e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Quality management in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of incidental FDG findings at extrapulmonary locations on duration of diagnosis and time to treatment in patients staged for lung cancer: Retrospective analysis
Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Pinar Celik, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, Arzu Yorgancioglu
Source:
International Congress 2015 – Quality management in lung cancer
Session:
Quality management in lung cancer
Session type:
Thematic Poster Session
Number:
4223
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Pinar Celik, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, Arzu Yorgancioglu. Effect of incidental FDG findings at extrapulmonary locations on duration of diagnosis and time to treatment in patients staged for lung cancer: Retrospective analysis. Eur Respir J 2015; 46: Suppl. 59, 4223
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Imaging of eosinophilic lung disease
Related content which might interest you:
Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Lung cancer risk based on visual assessment of emphysema and interstitial abnormalities in low dose chest CT
Source: International Congress 2014 – Different modalities and techniques for lung imaging
Year: 2014
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Mode of influence of the type of the chest wall invasion to the outcome of surgical treatment of patients with primary lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Benign lung tumors: Presentation, diagnosis, and outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Tuberculosis in patients with different lung neoplasm: The analysis of 17126 patients. MDCT with perfusion, virtual bronchoscopy and pulmonary angiography
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Combined endobronchial and esophageal endosonography for mediastinal staging in lung cancer: Systematic review and meta-analysis
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept